Nano Matters

Monitoring for Diabetic Foot Ulcers with Nanotechnology

Episode Summary

In this episode of Nano Matters, Linh Le, Founder and CEO of Flextrapower, discusses how his company uses nanotechnology to detect the formation of diabetic foot ulcers. If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov. Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/dUW9Cj0_EeA CREDITS Special thanks to: Linh Le Flextrapower Music: Inspirational Outlook by Scott Holmes https://www.freemusicarchive.org/music/Scott_Holmes/Inspiring__Upbeat_Music/Scott_Holmes_-_Inspirational_Outlook https://creativecommons.org/licenses/by-nc/4.0/legalcode Produced by: Mallory Hinks, Ph.D. Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.

Episode Notes

In this episode of Nano Matters, Linh Le, Founder and CEO of Flextrapower, discusses how his company uses nanotechnology to detect the formation of diabetic foot ulcers.  

 

If you would like to learn more about nanotechnology, go to nano.gov or email us at info@nnco.nano.gov.

 

Closed captioning is provided on our YouTube channel. For this episode, go to: https://youtu.be/dUW9Cj0_EeA

 

CREDITS

 

Special thanks to:  

Linh Le

Flextrapower

 

Music:  

Inspirational Outlook by Scott Holmes  

https://www.freemusicarchive.org/music/Scott_Holmes/Inspiring__Upbeat_Music/Scott_Holmes_-_Inspirational_Outlook

https://creativecommons.org/licenses/by-nc/4.0/legalcode

 

Produced by:  

Mallory Hinks, Ph.D.  

 

Any opinions, findings, conclusions, or recommendations expressed in this podcast are those of the guest and do not necessarily reflect the views of the National Nanotechnology Coordination Office or United States Government. Additionally, mention of trade names or commercial products does not constitute endorsement or recommendation by any of the aforementioned parties. Any mention of commercial products, processes, or services cannot be construed as an endorsement or recommendation.